Current Otorhinolaryngology Reports

, Volume 6, Issue 1, pp 56–63 | Cite as

Surgical Management of Thyroid Disease in Children

  • Roberto Solis
  • Allison Ordemann
  • Eric E. Berg
Pediatric Otolaryngology (I Bruce, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pediatric Otolaryngology


Purpose of Review

To provide a comprehensive, up-to-date guide for the surgical management of the most common malignant and benign thyroid diseases within the pediatric population.

Recent Findings

26.4% of nodules are malignant in the pediatric population. Concerning ultrasound features of hypoechogenicity, irregular margins, increased intranodular blood flow, or microcalcifications should prompt FNA, while size criteria is less important. The Bethesda System is effective in stratifying risk in pediatric nodules. The role of molecular genetic testing to guide patient management is emerging. Total thyroidectomy has become more frequent in the treatment of differentiated thyroid cancer due to its aggressive nature in the pediatric population and concern for recurrence. The role of adjunctive radiofrequency iodine ablation and the impact of extensive resection on survival are controversial.


Management of pediatric thyroid disease can be complex and should be managed by a multidisciplinary team with an experienced, high-volume surgeon.


Pediatric Thyroid Carcinoma Guidelines Nodule Surgery 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716–59. The first task force created guidelines for management of thyroid disease specifically in children as placed forward by the American Thyroid Association. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Guille JT, Opoku-Boateng A, Thibeault SL, Chen H. Evaluation and management of the pediatric thyroid nodule. Oncologist. 2015;20(1):19–27. Scholar
  3. 3.
    Buryk MA, Simons JP, Picarsic J, Monaco SE, Ozolek JA, Joyce J, et al. Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules. Thyroid. 2015;25(4):392–400. Scholar
  4. 4.
    Ly S, Frates MC, Benson CB, Peters HE, Grant FD, Drubach LA, et al. Features and outcome of autonomous thyroid nodules in children: 31 consecutive patients seen at a single center. J Clin Endocrinol Metab. 2016;101(10):3856–62. Scholar
  5. 5.
    • Lim-Dunham JE, Erdem Toslak I, Alsabban K, Aziz A, Martin B, Okur G, et al. Ultrasound risk stratification for malignancy using the 2015 American Thyroid Association Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Pediatr Radiol. 2017;47(4):429–36. Recent review evaluating the reproducibility of the ATA recommendations for fine needle aspiration of thyroid nodules in children based on imaging characteristics, and how it translates to estimating malignancy risk. CrossRefPubMedGoogle Scholar
  6. 6.
    Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab. 2013;98(8):3238–45. Scholar
  7. 7.
    Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–65. Scholar
  8. 8.
    Rossi ED, Martini M, Cenci T, Capodimonti S, Larocca LM. The role of thyroid FNA cytology in pediatric malignant lesions: an overview of the literature. Cancer 2017.Google Scholar
  9. 9.
    Monaco SE, Pantanowitz L, Khalbuss WE, Benkovich VA, Ozolek J, Nikiforova MN, et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol. 2012;120(5):342–50. Scholar
  10. 10.
    Amirazodi E, Propst EJ, Chung CT, Parra DA, Wasserman JD. Pediatric thyroid FNA biopsy: outcomes and impact on management over 24 years at a tertiary care center. Cancer Cytopathol. 2016;124(11):801–10. Scholar
  11. 11.
    Noureldine SI, Najafian A, Aragon Han P, Olson MT, Genther DJ, Schneider EB, et al. Evaluation of the effect of diagnostic molecular testing on the surgical decision-making process for patients with thyroid nodules. JAMA Otolaryngol Head Neck Surg. 2016;142(7):676–82. Scholar
  12. 12.
    Canfarotta M, Moote D, Finck C, Riba-Wolman R, Thaker S, Lerer TJ, et al. McGill thyroid nodule score in differentiating benign and malignant pediatric thyroid nodules: a pilot study. Otolaryngol Head Neck Surg 2017:194599817715629.Google Scholar
  13. 13.
    Diesen DL, Skinner MA. Pediatric thyroid cancer. Semin Pediatr Surg. 2012;21(1):44–50.CrossRefPubMedGoogle Scholar
  14. 14.
    Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK, et al. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev. 2011;32(6):798–826. Scholar
  15. 15.
    Suh CH, Baek JH, Choi YJ, Lee JH. Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2017;38(1):154–61. Scholar
  16. 16.
    Stulak JM, Grant CS, Farley DR, Thompson GB, van Heerden JA, Hay ID, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg. 2006;141(5):489–94; discussion 94-6. Scholar
  17. 17.
    Spinelli C, Strambi S, Rossi L, Bakkar S, Massimino M, Ferrari A, et al. Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients. J Endocrinol Investig. 2016;39(9):1055–9. Scholar
  18. 18.
    Sugino K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, et al. Papillary thyroid carcinoma in children and adolescents: long-term follow-up and clinical characteristics. World J Surg. 2015;39(9):2259–65. Scholar
  19. 19.
    • Nice T, Pasara S, Goldfarb M, Doski J, Goldin A, Gow KW, et al. Pediatric papillary thyroid cancer >1 cm: is total thyroidectomy necessary? J Pediatr Surg. 2015;50(6):1009–13. Recent review of 3861 pediatric papillary thyroid cancer patients with tumor size > 1cm using the national cancer database to determine the overall survival rates for patients undergoing total thyroidectomy versus partial thyroidectomy. CrossRefPubMedGoogle Scholar
  20. 20.
    Raval MV, Bentrem DJ, Stewart AK, Ko CY, Reynolds M. Utilization of total thyroidectomy for differentiated thyroid cancer in children. Ann Surg Oncol. 2010;17(10):2545–53. Scholar
  21. 21.
    Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34(6):1192–202. Scholar
  22. 22.
    Popovtzer A, Shpitzer T, Bahar G, Feinmesser R, Segal K. Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg. 2006;135(4):581–4. Scholar
  23. 23.
    Demidchik YE, Demidchik EP, Reiners C, Biko J, Mine M, Saenko VA, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg. 2006;243(4):525–32. Scholar
  24. 24.
    Lazar L, Lebenthal Y, Steinmetz A, Yackobovitch-Gavan M, Phillip M. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr. 2009;154(5):708–14. Scholar
  25. 25.
    Beasley NJ, Lee J, Eski S, Walfish P, Witterick I, Freeman JL. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 2002;128(7):825–8. Scholar
  26. 26.
    Mihailovic J, Nikoletic K, Srbovan D. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes. J Nucl Med. 2014;55(5):710–7. Scholar
  27. 27.
    Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J, Kropinska A, Pomorski L, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med. 2007;48(6):879–88. Scholar
  28. 28.
    Hong JC, Seo JW, Jang AL, Suh SH, Pak MG, Han SH, et al. The utility of intra-operative frozen section for the evaluation of microscopic extrathyroidal extension in papillary thyroid carcinoma. Clin Otolaryngol. 2017;42(6):1167–71. Scholar
  29. 29.
    Nixon IJ, Wang LY, Ganly I, Patel SG, Morris LG, Migliacci JC, et al. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg. 2016;103(3):218–25. Scholar
  30. 30.
    Enomoto K, Enomoto Y, Uchino S, Yamashita H, Noguchi S. Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence. Endocr J. 2013;60(5):629–35. Scholar
  31. 31.
    Golpanian S, Tashiro J, Sola JE, Allen C, Lew JI, Hogan AR, et al. Surgically treated pediatric nonpapillary thyroid carcinoma. Eur J Pediatr Surg. 2016;26(6):524–32. Scholar
  32. 32.
    Balachandar S, La Quaglia M, Tuttle RM, Heller G, Ghossein RA, Sklar CA. Pediatric differentiated thyroid carcinoma of follicular cell origin: prognostic significance of histologic subtypes. Thyroid. 2016;26(2):219–26. Scholar
  33. 33.
    Nagy R, Ganapathi S, Comeras I, Peterson C, Orloff M, Porter K, et al. Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid. 2011;21(5):505–10. Scholar
  34. 34.
    Spinelli C, Strambi S, Rossi L, Elisei R, Massimino M. Surgical management of medullary thyroid carcinoma in pediatric age. Curr Pediatr Rev. 2016;12(4):280–5. Scholar
  35. 35.
    Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610. Scholar
  36. 36.
    Wells SA, Pacini F, Robinson BG, Santoro M. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab. 2013;98(8):3149–64. Scholar
  37. 37.
    Gagel RF, Marx SJ. “Multiple endocrine neoplasia.” Williams Textbook of Endocrinology, Chapter 40, 11th ed., Philadelphia, and Eng C, Clayton D, et al. 2008.Google Scholar
  38. 38.
    Grubbs EG, Gagel RF. My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A! J Clin Endocrinol Metab. 2015;100(7):2532–5.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Iacobone M, Citton M, Viel G, Schiavone D, Torresan F. Surgical approaches in hereditary endocrine tumors. Updat Surg. 2017;69(2):181–91. Scholar
  40. 40.
    Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, et al. The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J Clin Endocrinol Metab. 2012;97(2):426–35. Scholar
  41. 41.
    Rivkees SA. Pediatric Graves’ disease: management in the post-propylthiouracil era. Int J Pediatr Endocrinol. 2014;2014(1):10. Scholar
  42. 42.
    Léger J, Carel JC. Hyperthyroidism in childhood: causes, when and how to treat. J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):50–6.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Minamitani K, Sato H, Ohye H, Harada S, Arisaka O, Committee on Pharmaceutical Affairs JSfPE, and the Pediatric Thyroid Disease Committee, J.pan Thyroid Association (Taskforce for the Revision of the Guidelines for the Treatment of Childhood-Onset Graves’ Disease). Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016. Clin Pediatr Endocrinol. 2017;26(2):29–62. Scholar
  44. 44.
    Rivkees SA. 63 years and 715 days to the “boxed warning”: unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol 2010;2010.Google Scholar
  45. 45.
    Elfenbein DM, Katz M, Schneider DF, Chen H, Sippel RS. Thyroidectomy for Graves’ disease in children: indications and complications. J Pediatr Surg. 2016;51(10):1680–3. Scholar
  46. 46.
    Breuer CK, Solomon D, Donovan P, Rivkees SA, Udelsman R. Effect of patient age on surgical outcomes for Graves’ disease: a case-control study of 100 consecutive patients at a high volume thyroid surgical center. Int J Pediatr Endocrinol. 2013;2013(1):1. Scholar
  47. 47.
    • Kundel A, Thompson GB, Richards ML, Qiu LX, Cai Y, Schwenk FW, et al. Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic. J Clin Endocrinol Metab. 2014;99(2):399–406. Recent review conducted at the Mayo Clinic reporting their operative experience and outcomes of 241 cases of children < 19 years old performed by high-volume endocrine surgeons. CrossRefPubMedGoogle Scholar
  48. 48.
    Burke JF, Sippel RS, Chen H. Evolution of pediatric thyroid surgery at a tertiary medical center. J Surg Res. 2012;177(2):268–74. Scholar
  49. 49.
    Breuer C, Tuggle C, Solomon D, Sosa JA. Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children? J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):79–85.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg. 2010;34(6):1239–46. Scholar
  51. 51.
    Kluijfhout WP, van Beek DJ, Verrijn Stuart AA, Lodewijk L, Valk GD, van der Zee DC, et al. Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2: retrospective cohort analysis. Medicine (Baltimore). 2015;94(29):e1108. Scholar
  52. 52.
    Schietroma M, Cecilia EM, Carlei F, Sista F, De Santis G, Lancione L, et al. Dexamethasone for the prevention of recurrent laryngeal nerve palsy and other complications after thyroid surgery: a randomized double-blind placebo-controlled trial. JAMA Otolaryngol Head Neck Surg. 2013;139(5):471–8. Scholar
  53. 53.
    Piccirillo JF, Bauchner H. Expression of concern: Schietroma M, Cecilia EM, Carlei F, Sista F, De Santis G, Lancione L, Amicucci G. Dexamethasone for the prevention of recurrent laryngeal nerve palsy and other complications after thyroid surgery: a randomized double-blind placebo-controlled trial. JAMA Otolaryngol Head Neck Surg 2013;139(5):471–478. doi:10.1001/jamaoto.2013.2821. JAMA Otolaryngol Head Neck Surg. 2017;
  54. 54.
    Chung TK, Rosenthal EL, Porterfield JR, Carroll WR, Richman J, Hawn MT. Examining national outcomes after thyroidectomy with nerve monitoring. J Am Coll Surg. 2014;219(4):765–70. Scholar
  55. 55.
    Stack BC, Bimston DN, Bodenner DL, Brett EM, Dralle H, Orloff LA, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Disease State clinical review: postoperative hypoparathyroidism—definitions and management. Endocr Pract. 2015;21(6):674–85. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Roberto Solis
    • 1
  • Allison Ordemann
    • 2
  • Eric E. Berg
    • 2
    • 3
  1. 1.Paul L. Foster School of MedicineTexas Tech University Health Sciences CenterEl PasoUSA
  2. 2.Department of Otolaryngology- Head and Neck SurgeryUniversity of Texas- SouthwesternDallasUSA
  3. 3.Department of Otolaryngology, Head and Neck SurgeryUT Southwestern and Children’s Medical Center DallasDallasUSA

Personalised recommendations